Many cell culture models have been used to simulate the liver environment for research and development. Some of these hepatocyte models include tumor cell lines such as Huh-7 and HepG2 cells. Tumor cell lines include the advantage of self-renewal, which saves resources and enables the more rapid production of genetic models for mechanistic research. However, the metabolic activity of tumor lines is 10-1,000 orders of magnitude less than that of primary hepatocytes and are not recommended for toxicity studies in the drug discovery and development process where appropriate drug metabolism might be important.
Lonza supplies a more biologically relevant hepatic cell line, HepaRG™ Cells. These cells are fully-functional, adult-phenotype, human hepatic cells. HepaRG™ Cells exhibit many characteristics similar to primary human hepatocytes and can be used for many of the same applications. The increased metabolic activity of HepaRG™ Cells compared to HepG2 enables more predictive value for hepatic toxicity assays conducted in early drug discovery.
The NoSpin HepaRG™ Cells are provided in a convenient, terminally differentiated, cryopreserved format that does not require the user to centrifuge, resuspend, or count the cells after thawing. This eliminates multiple steps that introduce qualitative and quantitative variability and benefits high-volume labs by reducing the time and effort needed to perform an assay. Each lot of HepaRG™has consistent yield, viability, and functionality across multiple applications.